Children's Hospital of Philadelphia and Penn Medicine Launch First CRISPR-Based Platform to Pinpoint Drivers of Acute Myeloid Leukemia in Patient Cells
PR Newswire —
New Toolkit Allows Researchers to Test Potential Cancer Targets Directly in Patient-Leukemia Cells PHILADELPHIA, Feb. 26, 2026 /PRNewswire/ -- A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia...